Literature DB >> 742872

UK-18,892: resistance to modification by aminoglycoside-inactivating enzymes.

R J Andrews, K W Brammer, H E Cheeseman, S Jevons.   

Abstract

UK-18,892, a new semisynthetic aminoglycoside, was active against bacteria possessing aminoglycoside-inactivating enzymes, with the exception of some known to possess AAC(6') or AAD(4') enzymes. This activity has been rationalized by using cell-free extracts of bacteria containing known inactivating enzymes, where it was shown that UK-18,892 was not a substrate for the APH(3'), AAD(2''), AAC(3), and AAC(2') enzymes. It was also demonstrated that UK-18,892 protected mice against lethal infections caused by organisms possessing aminoglycoside-inactivating enzymes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 742872      PMCID: PMC352568          DOI: 10.1128/AAC.14.6.846

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  R-factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics.

Authors:  R Benveniste; J Davies
Journal:  FEBS Lett       Date:  1971-05-20       Impact factor: 4.124

2.  Improved acetylating radioenzymatic assay of amikacin, tobramycin, and sisomicin in serum.

Authors:  P Stevens; L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

3.  Aminoglycoside-modifying enzymes.

Authors:  M J Haas; J E Dowding
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

Review 4.  Mechanisms of antibiotic resistance in bacteria.

Authors:  R Benveniste; J Davies
Journal:  Annu Rev Biochem       Date:  1973       Impact factor: 23.643

5.  Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor.

Authors:  R Benveniste; J Davies
Journal:  Biochemistry       Date:  1971-05-11       Impact factor: 3.162

6.  Aminoglycoside antibiotics: inactivation by phosphorylation in Escherichia coli carrying R factors.

Authors:  B Ozanne; R Benveniste; D Tipper; J Davies
Journal:  J Bacteriol       Date:  1969-11       Impact factor: 3.490

7.  Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives.

Authors:  K Richardson; S Jevons; J W Moore; B C Ross; J R Wright
Journal:  J Antibiot (Tokyo)       Date:  1977-10       Impact factor: 2.649

8.  New plasmid-mediated nucleotidylation of aminoglycoside antibiotics in Staphlococcus aureus.

Authors:  F Le Goffic; A Martel; M L Capmau; B Baca; P Goebel; H Chardon; C J Soussy; J Duval; D H Bouanchaud
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

9.  Aminoglycoside resistance in bacteria medicated by gentamicin acetyltransferase II, an enzyme modifying the 2'-amino group of aminoglycoside antibiotics.

Authors:  M Chevereau; P J Daniels; J Davies; F LeGoffic
Journal:  Biochemistry       Date:  1974-01-29       Impact factor: 3.162

10.  Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.

Authors:  K E Price; T A Pursiano; M D DeFuria
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

  10 in total
  1 in total

Review 1.  Aminoglycoside research 1975-1985: prospects for development of improved agents.

Authors:  K E Price
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.